EX-21.1 9 ex211to10k20221231.htm EX-21.1
Exhibit 21.1
Subsidiaries of Lisata Therapeutics, Inc.

Entity |  | Percentage of Ownership |  | Location
Amorcyte, LLC |  | 100% |  | United States of America
Athelos Corporation (1) |  | 99% |  | United States of America
Cend Therapeutics, Inc. |  | 100% |  | United States of America
NeoStem Oncology, LLC |  | 100% |  | United States of America
Lisata Therapeutics Australia Pty Ltd |  | 100% |  | Australia
Lisata Therapeutics Ireland Limited |  | 100% |  | Ireland
Lisata Therapeutics KK |  | 100% |  | Japan
Lisata Therapeutics (U.K.) Limited |  | 100% |  | United Kingdom

(1) As of December 31, 2022, Becton Dickinson's ownership interest in Athelos Corporation was 1.0%.